Thu, Mar 5, 2015, 12:12 AM EST - U.S. Markets open in 9 hrs 18 mins

Recent

% | $
Quotes you view appear here for quick access.

Cellceutix Corporation Message Board

ogewen 7 posts  |  Last Activity: Feb 11, 2015 3:14 PM Member since: Apr 23, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    To Tommy K and thoughts on DDD

    by ogewen Feb 11, 2015 2:59 PM
    ogewen ogewen Feb 11, 2015 3:14 PM Flag

    Hi lilly, good to see you too, are we the dinosaurs of 3D past? I'm in it for the long ride, don't need the income. Made a small fortune on paper and then lost a small fortune on paper :). But I'm still OK since my cost basis is in the teens. I'm just waiting for the rip tide to end. All the best Ogewen

  • Thank you for your kind words. It is truly appreciated. I don't take the venomous words spewed y the individual in question to heart since it is coming from a person with serious mental issues. At times I misconstrue what is being said as English is my second language, but my intent is to share my thoughts and my assessment of various companies that I have done my DD on. I was wrong in the pps of 3D would be at this time, but I still stand by my opinion that 3D will reach the $200 level . Determining the timing is the tricky part of that equation. IMHO Avi's lack of leadership and failure to get ahead of all the negativity being disseminating in the likes of SA, Cramer, et al, is disheartening to us shareholders. That being said, however, doesn't lessen the strength of 3D going forward. Soon the media darling SSYS will come back to earth and positive earnings in the next few Q filings will be significant improvement from past reports. Most of the acquisitions of the past 24 months will be accretive for greater earnings. I don't trade but invest and I'm in for the long term so I'm not concerned. Realistically I would not be surprised if we see a return to previous high of the 90's by EOY, but we'll see. It's a great company with impressive vision and still in its infancy. My main concern is if Avi can effectively lead the company properly. I welcome all intelligent opinions and discussions pro or con to that of mine. I'm here to learn and share thoughts, but in a respective manner. As always, all the best Ogewen.

  • ogewen ogewen Feb 11, 2015 2:58 PM Flag

    Thank you for your kind words. It is truly appreciated. I don't take the venomous words spewed y the individual in question to heart since it is coming from a person with serious mental issues. At times I misconstrue what is being said as English is my second language, but my intent is to share my thoughts and my assessment of various companies that I have done my DD on. I was wrong in the pps of 3D would be at this time, but I still stand by my opinion that 3D will reach the $200 level . Determining the timing is the tricky part of that equation. IMHO Avi's lack of leadership and failure to get ahead of all the negativity being disseminating in the likes of SA, Cramer, et al, is disheartening to us shareholders. That being said, however, doesn't lessen the strength of 3D going forward. Soon the media darling SSYS will come back to earth and positive earnings in the next few Q filings will be significant improvement from past reports. Most of the acquisitions of the past 24 months will be accretive for greater earnings. I don't trade but invest and I'm in for the long term so I'm not concerned. Realistically I would not be surprised if we see a return to previous high of the 90's by EOY, but we'll see. It's a great company with impressive vision and still in its infancy. My main concern is if Avi can effectively lead the company properly. I welcome all intelligent opinions and discussions pro or con to that of mine. I'm here to learn and share thoughts, but in a respective manner. As always, all the best Ogewen.

  • Reply to

    Future is Golden part 1

    by ogewen Dec 8, 2014 11:04 AM
    ogewen ogewen Dec 10, 2014 9:30 AM Flag

    Bump...Thought this was pertinent to see since I wrote about Prurisol 2 days ago, source in Switzerland gave me info on P... incidentally Roche is a Swiss company, food for thought. All the best Ogewen

    Sentiment: Strong Buy

  • Reply to

    $5 is the magic number

    by cyoung8404 Dec 8, 2014 11:52 AM
    ogewen ogewen Dec 8, 2014 12:00 PM Flag

    They can't invest until it uplists to NASDAQ or NYSE, but that might happen soon. Then you will be correct. All the best. Ogewen

  • Now if you throw in B and K into the mix which is getting all the attention and rightfully so since they both are life saving drugs the pps could easily be in the $300-500 range near term. I can't even count the number of times the antibiotics that were failsafe that I treated patients with that became obsolete and ineffective in the past few years. The mutation of bacteria is advancing exponentially and as a doctor treating eye diseases is beyond alarming. B is a defensin-mimetic that is not susceptible to traditional drug resistance. With B alone CTIX could be in the above pps category. K would explode the pps to even greater heights. I won't bore all the knowledgeable investors on this MB with the salient facts regarding K. I've gone on too long as it is and I apologize for the lack of brevity. I thought it was time for all of us to take a step back and realize how powerful the CTIX arsenal is at this early point of time. Once again please accept my apology for this long quazi- dissertation. I welcome intelligent discussion whether they be pro or con. As you probably surmise I am long and have been since CTIX has been in the $1 pps. GTLA. All the best. Ogewen

    Sentiment: Strong Buy

  • It's been a while since I posted. CTIX could be comparable to AAPL in it's infancy only time will tell. Their immediate pipeline is remarkable to say the least. Most fledgling biopharma companies have only one drug in its pipeline. CTIX has 3 and all of them are in disparate areas of treatment. Prurisol is the sleeper, but in of itself could be seen as a blockbuster. Psoriasis is a global affliction . The worldwide prevalence of psoriasis is around 2%, (That's 70 to 140 million people) but studies in developed countries have reported higher prevalence rates of on average about 4.6%. Ten percent go on to develop arthritis. Psoriasis is a noncommunicable disease that manifests as a chronic inflammatory skin disease. Being an autoimmune disease it has been linked to other conditions such as ulcerative colitis and many more. It's uniqueness in treating this affliction is that it portends to not only treat symptomatically, but it's application is curative and treated systemically. Studies in Europe which are further along than US show remarkable results. I traveled there recently and heard "off the record" that it is the real deal. We'll see. That alone could give CTIX a $75-100 pps in the immediate future. Ran out of room will cont. with part 2

CTIX
3.66-0.10(-2.66%)Mar 4 3:46 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.